David Morgan

Professor

Michigan State University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Morgan is a Professor at Michigan State University, USA. His research focuses on neurodegenerative diseases, particularly Alzheimer's and Parkinson's disease, with recent works examining immune modulation, neuroinflammation, and therapeutic treatments. He has conducted studies on the associations between neuromelanin depletion and cortical activity, as well as the validation of human models to explore Alzheimer's disease therapies.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (4)

Alex Wiesman

Assistant Professor

Simon Fraser University

CANADA

View details

D. Louis Collins

Professor

McGill University

CANADA

View details

Delphine Boche

University of Southampton

UNITED KINGDOM

View details

Alain Dagher

Professor

McGill University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Morgan

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Immune modulation to treat Alzheimer's disease.

Therapeutic Treatment With OLX-07010 Inhibited Tau Aggregation and Ameliorated Motor Deficits in an Aged Mouse Model of Tauopathy.

Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson's disease

Neuroinflammation in Alzheimer disease.

Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challenges.

Validation of a functional human AD model with four AD therapeutics utilizing patterned ipsc-derived cortical neurons integrated with microelectrode arrays.

A functional aged human iPSC-cortical neuron model recapitulates Alzheimer's disease, senescence, and the response to therapeutics.

Rural-Urban mild cognitive impairment comparison in West Michigan through EHR.

Longer sleep duration and neuroinflammation in at-risk elderly with a parental history of Alzheimer's disease.

Induction of tauopathy in a mouse model of amyloidosis using intravenous administration of adeno-associated virus vectors expressing human P301L tau.

Collaborators (4)

Alex Wiesman

D. Louis Collins

Delphine Boche

Alain Dagher

Make your next move.